 | • レポートコード：QYR2104Z4985 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、腎疾患のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（急性腎障害、慢性腎疾患、その他）、用途別市場規模（病院、診療所、研究センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・腎疾患の市場動向 ・企業の競争状況、市場シェア ・腎疾患の種類別市場規模（急性腎障害、慢性腎疾患、その他） ・腎疾患の用途別市場規模（病院、診療所、研究センター、その他） ・腎疾患の北米市場規模2016-2027（アメリカ、カナダ） ・腎疾患のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・腎疾患のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腎疾患の中南米市場規模2016-2027（メキシコ、ブラジル） ・腎疾患の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott (US)、Amgen Inc. (US)、Baxter (US)、Bristol-Myers Squibb Company (US)、Keryx Biopharmaceuticals(US)、NephroGenex(US)、Novartis AG (Switzerland)、Pfizer Inc.(US)、Sanofi (France)、Shire Pharmaceuticals Limited (Republic of Ireland)） ・結論 |
Renal disease also known as kidney diseases that affects the functioning of kidneys. According to National Kidney Foundation, Inc., 10% of world’s population is suffering from chronic kidney diseases.
Considering the global scenario of the market, North America is believed to be the largest market for global renal disease. Moreover the European market is the second largest market for global renal disease and Western Europe region is the dominating the market in Europe. On the other hand, Asia-Pacific (APAC) is expected to grow at significant rate in the global renal disease market during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of disease and treatment.
Market Analysis and Insights: Global Renal Disease Market
The global Renal Disease market size is projected to reach US$ 124820 million by 2026, from US$ 97290 million in 2019, at a CAGR of 3.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Renal Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Renal Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Renal Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Renal Disease market.
Global Renal Disease Scope and Market Size
Renal Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Renal Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Acute Kidney Problems
Chronic Kidney Diseases
Others
Segment by Application
Hospital
Clinic
Research Center
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott (US)
Amgen Inc. (US)
Baxter (US)
Bristol-Myers Squibb Company (US)
Keryx Biopharmaceuticals(US)
NephroGenex(US)
Novartis AG (Switzerland)
Pfizer Inc.(US)
Sanofi (France)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acute Kidney Problems
1.2.3 Chronic Kidney Diseases
1.2.4 Others
1.3 Market by Application
1.3.1 Global Renal Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Renal Disease Market Perspective (2016-2027)
2.2 Renal Disease Growth Trends by Regions
2.2.1 Renal Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Renal Disease Historic Market Share by Regions (2016-2021)
2.2.3 Renal Disease Forecasted Market Size by Regions (2022-2027)
2.3 Renal Disease Industry Dynamic
2.3.1 Renal Disease Market Trends
2.3.2 Renal Disease Market Drivers
2.3.3 Renal Disease Market Challenges
2.3.4 Renal Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Renal Disease Players by Revenue
3.1.1 Global Top Renal Disease Players by Revenue (2016-2021)
3.1.2 Global Renal Disease Revenue Market Share by Players (2016-2021)
3.2 Global Renal Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Renal Disease Revenue
3.4 Global Renal Disease Market Concentration Ratio
3.4.1 Global Renal Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Disease Revenue in 2020
3.5 Renal Disease Key Players Head office and Area Served
3.6 Key Players Renal Disease Product Solution and Service
3.7 Date of Enter into Renal Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Disease Breakdown Data by Type
4.1 Global Renal Disease Historic Market Size by Type (2016-2021)
4.2 Global Renal Disease Forecasted Market Size by Type (2022-2027)
5 Renal Disease Breakdown Data by Application
5.1 Global Renal Disease Historic Market Size by Application (2016-2021)
5.2 Global Renal Disease Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Renal Disease Market Size (2016-2027)
6.2 North America Renal Disease Market Size by Type
6.2.1 North America Renal Disease Market Size by Type (2016-2021)
6.2.2 North America Renal Disease Market Size by Type (2022-2027)
6.2.3 North America Renal Disease Market Size by Type (2016-2027)
6.3 North America Renal Disease Market Size by Application
6.3.1 North America Renal Disease Market Size by Application (2016-2021)
6.3.2 North America Renal Disease Market Size by Application (2022-2027)
6.3.3 North America Renal Disease Market Size by Application (2016-2027)
6.4 North America Renal Disease Market Size by Country
6.4.1 North America Renal Disease Market Size by Country (2016-2021)
6.4.2 North America Renal Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Renal Disease Market Size (2016-2027)
7.2 Europe Renal Disease Market Size by Type
7.2.1 Europe Renal Disease Market Size by Type (2016-2021)
7.2.2 Europe Renal Disease Market Size by Type (2022-2027)
7.2.3 Europe Renal Disease Market Size by Type (2016-2027)
7.3 Europe Renal Disease Market Size by Application
7.3.1 Europe Renal Disease Market Size by Application (2016-2021)
7.3.2 Europe Renal Disease Market Size by Application (2022-2027)
7.3.3 Europe Renal Disease Market Size by Application (2016-2027)
7.4 Europe Renal Disease Market Size by Country
7.4.1 Europe Renal Disease Market Size by Country (2016-2021)
7.4.2 Europe Renal Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Renal Disease Market Size (2016-2027)
8.2 Asia-Pacific Renal Disease Market Size by Type
8.2.1 Asia-Pacific Renal Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Renal Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Renal Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Renal Disease Market Size by Application
8.3.1 Asia-Pacific Renal Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Renal Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Renal Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Renal Disease Market Size by Region
8.4.1 Asia-Pacific Renal Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Renal Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Renal Disease Market Size (2016-2027)
9.2 Latin America Renal Disease Market Size by Type
9.2.1 Latin America Renal Disease Market Size by Type (2016-2021)
9.2.2 Latin America Renal Disease Market Size by Type (2022-2027)
9.2.3 Latin America Renal Disease Market Size by Type (2016-2027)
9.3 Latin America Renal Disease Market Size by Application
9.3.1 Latin America Renal Disease Market Size by Application (2016-2021)
9.3.2 Latin America Renal Disease Market Size by Application (2022-2027)
9.3.3 Latin America Renal Disease Market Size by Application (2016-2027)
9.4 Latin America Renal Disease Market Size by Country
9.4.1 Latin America Renal Disease Market Size by Country (2016-2021)
9.4.2 Latin America Renal Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Renal Disease Market Size (2016-2027)
10.2 Middle East & Africa Renal Disease Market Size by Type
10.2.1 Middle East & Africa Renal Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Renal Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Renal Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Renal Disease Market Size by Application
10.3.1 Middle East & Africa Renal Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Renal Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Renal Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Renal Disease Market Size by Country
10.4.1 Middle East & Africa Renal Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Renal Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott (US)
11.1.1 Abbott (US) Company Details
11.1.2 Abbott (US) Business Overview
11.1.3 Abbott (US) Renal Disease Introduction
11.1.4 Abbott (US) Revenue in Renal Disease Business (2016-2021)
11.1.5 Abbott (US) Recent Development
11.2 Amgen Inc. (US)
11.2.1 Amgen Inc. (US) Company Details
11.2.2 Amgen Inc. (US) Business Overview
11.2.3 Amgen Inc. (US) Renal Disease Introduction
11.2.4 Amgen Inc. (US) Revenue in Renal Disease Business (2016-2021)
11.2.5 Amgen Inc. (US) Recent Development
11.3 Baxter (US)
11.3.1 Baxter (US) Company Details
11.3.2 Baxter (US) Business Overview
11.3.3 Baxter (US) Renal Disease Introduction
11.3.4 Baxter (US) Revenue in Renal Disease Business (2016-2021)
11.3.5 Baxter (US) Recent Development
11.4 Bristol-Myers Squibb Company (US)
11.4.1 Bristol-Myers Squibb Company (US) Company Details
11.4.2 Bristol-Myers Squibb Company (US) Business Overview
11.4.3 Bristol-Myers Squibb Company (US) Renal Disease Introduction
11.4.4 Bristol-Myers Squibb Company (US) Revenue in Renal Disease Business (2016-2021)
11.4.5 Bristol-Myers Squibb Company (US) Recent Development
11.5 Keryx Biopharmaceuticals(US)
11.5.1 Keryx Biopharmaceuticals(US) Company Details
11.5.2 Keryx Biopharmaceuticals(US) Business Overview
11.5.3 Keryx Biopharmaceuticals(US) Renal Disease Introduction
11.5.4 Keryx Biopharmaceuticals(US) Revenue in Renal Disease Business (2016-2021)
11.5.5 Keryx Biopharmaceuticals(US) Recent Development
11.6 NephroGenex(US)
11.6.1 NephroGenex(US) Company Details
11.6.2 NephroGenex(US) Business Overview
11.6.3 NephroGenex(US) Renal Disease Introduction
11.6.4 NephroGenex(US) Revenue in Renal Disease Business (2016-2021)
11.6.5 NephroGenex(US) Recent Development
11.7 Novartis AG (Switzerland)
11.7.1 Novartis AG (Switzerland) Company Details
11.7.2 Novartis AG (Switzerland) Business Overview
11.7.3 Novartis AG (Switzerland) Renal Disease Introduction
11.7.4 Novartis AG (Switzerland) Revenue in Renal Disease Business (2016-2021)
11.7.5 Novartis AG (Switzerland) Recent Development
11.8 Pfizer Inc.(US)
11.8.1 Pfizer Inc.(US) Company Details
11.8.2 Pfizer Inc.(US) Business Overview
11.8.3 Pfizer Inc.(US) Renal Disease Introduction
11.8.4 Pfizer Inc.(US) Revenue in Renal Disease Business (2016-2021)
11.8.5 Pfizer Inc.(US) Recent Development
11.9 Sanofi (France)
11.9.1 Sanofi (France) Company Details
11.9.2 Sanofi (France) Business Overview
11.9.3 Sanofi (France) Renal Disease Introduction
11.9.4 Sanofi (France) Revenue in Renal Disease Business (2016-2021)
11.9.5 Sanofi (France) Recent Development
11.10 Shire Pharmaceuticals Limited (Republic of Ireland)
11.10.1 Shire Pharmaceuticals Limited (Republic of Ireland) Company Details
11.10.2 Shire Pharmaceuticals Limited (Republic of Ireland) Business Overview
11.10.3 Shire Pharmaceuticals Limited (Republic of Ireland) Renal Disease Introduction
11.10.4 Shire Pharmaceuticals Limited (Republic of Ireland) Revenue in Renal Disease Business (2016-2021)
11.10.5 Shire Pharmaceuticals Limited (Republic of Ireland) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Renal Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Acute Kidney Problems
Table 3. Key Players of Chronic Kidney Diseases
Table 4. Key Players of Others
Table 5. Global Renal Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Renal Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Renal Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Renal Disease Market Share by Regions (2016-2021)
Table 9. Global Renal Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Renal Disease Market Share by Regions (2022-2027)
Table 11. Renal Disease Market Trends
Table 12. Renal Disease Market Drivers
Table 13. Renal Disease Market Challenges
Table 14. Renal Disease Market Restraints
Table 15. Global Renal Disease Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Renal Disease Market Share by Players (2016-2021)
Table 17. Global Top Renal Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Disease as of 2020)
Table 18. Ranking of Global Top Renal Disease Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Renal Disease Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Renal Disease Product Solution and Service
Table 22. Date of Enter into Renal Disease Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Renal Disease Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Renal Disease Revenue Market Share by Type (2016-2021)
Table 26. Global Renal Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Renal Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Renal Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Renal Disease Revenue Market Share by Application (2016-2021)
Table 30. Global Renal Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Renal Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Renal Disease Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Renal Disease Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Renal Disease Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Renal Disease Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Renal Disease Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Renal Disease Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Renal Disease Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Renal Disease Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Renal Disease Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Renal Disease Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Renal Disease Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Renal Disease Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Renal Disease Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Renal Disease Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Renal Disease Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Renal Disease Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Renal Disease Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Renal Disease Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Renal Disease Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Renal Disease Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Renal Disease Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Renal Disease Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Renal Disease Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Renal Disease Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Renal Disease Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Renal Disease Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Renal Disease Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Renal Disease Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Renal Disease Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Renal Disease Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott (US) Company Details
Table 63. Abbott (US) Business Overview
Table 64. Abbott (US) Renal Disease Product
Table 65. Abbott (US) Revenue in Renal Disease Business (2016-2021) & (US$ Million)
Table 66. Abbott (US) Recent Development
Table 67. Amgen Inc. (US) Company Details
Table 68. Amgen Inc. (US) Business Overview
Table 69. Amgen Inc. (US) Renal Disease Product
Table 70. Amgen Inc. (US) Revenue in Renal Disease Business (2016-2021) & (US$ Million)
Table 71. Amgen Inc. (US) Recent Development
Table 72. Baxter (US) Company Details
Table 73. Baxter (US) Business Overview
Table 74. Baxter (US) Renal Disease Product
Table 75. Baxter (US) Revenue in Renal Disease Business (2016-2021) & (US$ Million)
Table 76. Baxter (US) Recent Development
Table 77. Bristol-Myers Squibb Company (US) Company Details
Table 78. Bristol-Myers Squibb Company (US) Business Overview
Table 79. Bristol-Myers Squibb Company (US) Renal Disease Product
Table 80. Bristol-Myers Squibb Company (US) Revenue in Renal Disease Business (2016-2021) & (US$ Million)
Table 81. Bristol-Myers Squibb Company (US) Recent Development
Table 82. Keryx Biopharmaceuticals(US) Company Details
Table 83. Keryx Biopharmaceuticals(US) Business Overview
Table 84. Keryx Biopharmaceuticals(US) Renal Disease Product
Table 85. Keryx Biopharmaceuticals(US) Revenue in Renal Disease Business (2016-2021) & (US$ Million)
Table 86. Keryx Biopharmaceuticals(US) Recent Development
Table 87. NephroGenex(US) Company Details
Table 88. NephroGenex(US) Business Overview
Table 89. NephroGenex(US) Renal Disease Product
Table 90. NephroGenex(US) Revenue in Renal Disease Business (2016-2021) & (US$ Million)
Table 91. NephroGenex(US) Recent Development
Table 92. Novartis AG (Switzerland) Company Details
Table 93. Novartis AG (Switzerland) Business Overview
Table 94. Novartis AG (Switzerland) Renal Disease Product
Table 95. Novartis AG (Switzerland) Revenue in Renal Disease Business (2016-2021) & (US$ Million)
Table 96. Novartis AG (Switzerland) Recent Development
Table 97. Pfizer Inc.(US) Company Details
Table 98. Pfizer Inc.(US) Business Overview
Table 99. Pfizer Inc.(US) Revenue in Renal Disease Business (2016-2021) & (US$ Million)
Table 100. Pfizer Inc.(US) Recent Development
Table 101. Sanofi (France) Company Details
Table 102. Sanofi (France) Business Overview
Table 103. Sanofi (France) Renal Disease Product
Table 104. Sanofi (France) Revenue in Renal Disease Business (2016-2021) & (US$ Million)
Table 105. Sanofi (France) Recent Development
Table 106. Shire Pharmaceuticals Limited (Republic of Ireland) Company Details
Table 107. Shire Pharmaceuticals Limited (Republic of Ireland) Business Overview
Table 108. Shire Pharmaceuticals Limited (Republic of Ireland) Renal Disease Product
Table 109. Shire Pharmaceuticals Limited (Republic of Ireland) Revenue in Renal Disease Business (2016-2021) & (US$ Million)
Table 110. Shire Pharmaceuticals Limited (Republic of Ireland) Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Renal Disease Market Share by Type: 2020 VS 2027
Figure 2. Acute Kidney Problems Features
Figure 3. Chronic Kidney Diseases Features
Figure 4. Others Features
Figure 5. Global Renal Disease Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Research Center Case Studies
Figure 9. Others Case Studies
Figure 10. Renal Disease Report Years Considered
Figure 11. Global Renal Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Renal Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Renal Disease Market Share by Regions: 2020 VS 2027
Figure 14. Global Renal Disease Market Share by Regions (2022-2027)
Figure 15. Global Renal Disease Market Share by Players in 2020
Figure 16. Global Top Renal Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Disease as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Renal Disease Revenue in 2020
Figure 18. Global Renal Disease Revenue Market Share by Type (2016-2021)
Figure 19. Global Renal Disease Revenue Market Share by Type (2022-2027)
Figure 20. North America Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Renal Disease Market Share by Type (2016-2027)
Figure 22. North America Renal Disease Market Share by Application (2016-2027)
Figure 23. North America Renal Disease Market Share by Country (2016-2027)
Figure 24. United States Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Renal Disease Market Share by Type (2016-2027)
Figure 28. Europe Renal Disease Market Share by Application (2016-2027)
Figure 29. Europe Renal Disease Market Share by Country (2016-2027)
Figure 30. Germany Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Renal Disease Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Renal Disease Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Renal Disease Market Share by Region (2016-2027)
Figure 40. China Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Renal Disease Market Share by Type (2016-2027)
Figure 48. Latin America Renal Disease Market Share by Application (2016-2027)
Figure 49. Latin America Renal Disease Market Share by Country (2016-2027)
Figure 50. Mexico Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Renal Disease Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Renal Disease Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Renal Disease Market Share by Country (2016-2027)
Figure 56. Turkey Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Renal Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott (US) Revenue Growth Rate in Renal Disease Business (2016-2021)
Figure 60. Amgen Inc. (US) Revenue Growth Rate in Renal Disease Business (2016-2021)
Figure 61. Baxter (US) Revenue Growth Rate in Renal Disease Business (2016-2021)
Figure 62. Bristol-Myers Squibb Company (US) Revenue Growth Rate in Renal Disease Business (2016-2021)
Figure 63. Keryx Biopharmaceuticals(US) Revenue Growth Rate in Renal Disease Business (2016-2021)
Figure 64. NephroGenex(US) Revenue Growth Rate in Renal Disease Business (2016-2021)
Figure 65. Novartis AG (Switzerland) Revenue Growth Rate in Renal Disease Business (2016-2021)
Figure 66. Pfizer Inc.(US) Revenue Growth Rate in Renal Disease Business (2016-2021)
Figure 67. Sanofi (France) Revenue Growth Rate in Renal Disease Business (2016-2021)
Figure 68. Shire Pharmaceuticals Limited (Republic of Ireland) Revenue Growth Rate in Renal Disease Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の腎臓/腎機能検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Kidney/Renal Function Test Market The global Kidney/Renal Function Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …- 世界の慢性腎臓病（CKD）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chronic Kidney Disease (CKD) Market The global Chronic Kidney Disease (CKD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integri…
- 世界の急性腎不全治療市場規模・現状・予測（2021年-2027年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…
- 世界の急性腎不全治療市場規模・現状・予測（2021年-2027年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…
- 世界の多発性嚢胞腎治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Polycystic Kidney Disease Treatment Market The global Polycystic Kidney Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and hig…